VistaGen Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
VTGN
CUSIP
92840H400
Type
Equity
Class
COM
Num filings
58
Total reported value, excl. options
$2.54 M
Manager Report Date Value ($000) Shares Option Type